STAR-LLD (lenalidomide) Oral Controlled Release Development

About Bend Bioscience

Bend Bioscience is a private, revenue-generating CDMO focused on solving complex drug delivery challenges for small molecule therapeutics. The company has recently expanded its cGMP facilities in Oregon, adding four new suites to bolster its commercial spray drying and particle engineering capabilities. It positions itself as a full-service partner from concept to commercial supply, serving biopharma clients with a domestic U.S. operational base. Recent news includes a development agreement with Starton Therapeutics for an oral controlled-release formulation of lenalidomide.